Item 7.01 Regulation FD Disclosure.

On March 20, 2023, Dr. Nassim Usman, on behalf of Catalyst Biosciences, Inc. (the "Company"), gave a presentation (the "Corporate Presentation"). In addition, the Company posted the Corporate Presentation on its website, ir.catalystbiosciences.com. A copy of the Corporate Presentation is attached hereto as Exhibit 99.1.

The information in this Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in this Current Report shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits





(d) Exhibits

Exhibit
Number                                  Description
  99.1     Catalyst Biosciences March 20, 2023 Corporate Presentation Slide Deck.
104        Cover Page Interactive Data File (formatted as Inline XBRL).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses